Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
Tevogen Bio – April 9, 2025
Tevogen Bio – April 9, 2025
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
Tevogen Bio – April 8, 2025
Tevogen Bio – April 8, 2025
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
Tevogen Bio – April 7, 2025
Tevogen Bio – April 7, 2025
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
Tevogen Bio – March 26, 2025
Tevogen Bio – March 26, 2025
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
Tevogen Bio – March 25, 2025
Tevogen Bio – March 25, 2025
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
Tevogen Bio – March 7, 2025
Tevogen Bio – March 7, 2025
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel
Tevogen Bio – March 7, 2025
Tevogen Bio – March 7, 2025